ABSTRACT Src interactions with the plasma membrane are an important determinant of its activity. In turn, Src activity modulates its association with the membrane through binding of activated Src to phosphotyrosylated proteins. Caveolin-1 (Cav-1), a major component of caveolae, is a known Src phosphorylation target, and both were reported to regulate cell transformation. However, the nature of Src-Cav-1 interactions, a potential mechanism of their coregulation, remained unclear. Here we used fluorescence recovery after photobleaching beam-size analysis, coimmunoprecipitation, quantitative imaging, and far-Western studies with cells expressing wild type, as well as structural and activity mutants of Src-green fluorescent protein and Cav-1-monomeric red fluorescent protein, to measure their interactions with the membrane and with each other. We show dynamic Src-plasma membrane interactions, which are augmented and stabilized by Cav-1. The mechanism involves phosphorylation of Cav-1 at Tyr-14 by Src and subsequent binding of the Src SH2 domain to phospho-Cav-1, leading to accumulation of activated Src in focal adhesions. This novel Cav-1 function potentially modulates focal adhesion dynamics.
INTRODUCTION
The nonreceptor protein-tyrosine kinase c-Src is the prototype of the Src family of protein kinases (SFKs). It is associated with the plasma membrane, endosomal compartments, and cell adhesions and mediates responses involved in cellular differentiation, adhesion, and migration (Kaplan et al., 1992; Brown and Cooper, 1996; Schlaepfer et al., 1999; Abram and Courtneidge, 2000; Sandilands et al., 2007) . Constitutively active Src can transform cells in vitro (Martin, 2001; Courtneidge, 2002; Frame, 2004) , and increased c-Src expression or activity has been detected in multiple types of human cancer (Bjorge et al., 2000; Frame, 2002; Ishizawar and Parsons, 2004) . The first 16 N-terminal residues of Src (residue numbers refer to chicken c-Src) contain an N-myristoylation site and a series of basic residues, both required for membrane association (Resh, 1999 (Resh, , 2006 . This association is critical for Src signaling and intracellular distribution (Kamps et al., 1985; Buss et al., 1986; Resh, 1999 Resh, , 2006 . The N-terminal membrane anchor is followed by two protein interaction modules, the SH3 and SH2 domains, which are required both for inactivating intramolecular interactions and for Src targeting to and phosphorylation of protein substrates (Martin, 2001; Frame, 2004; Shvartsman et al., 2007; Oneyama et al., 2008) . The other half of the molecule contains the Src kinase domain, which mediates most of its biological functions, and a C-terminal regulatory domain; phosphorylation of Tyr-527 in this domain by C-terminal Src kinase (Csk) confers an inactive closed conformation, whereas mutations that prevent this phosphorylation (such as Y527F) result in a constitutively active open conformation (Martin, 2001;  cholesterol depletion, selectively enhances the association of active Src with the plasma membrane, retards its lateral diffusion, and preferentially targets active Src to FAs, opposite to the effect of Cbp.
RESULTS

Cav-1 selectively enhances membrane association of activated Src
To investigate the effects of Cav-1 on the dynamics of Src interactions with the plasma membrane and their potential dependence on its activation state, we expressed Src-WT-green fluorescent protein (GFP) or constitutively active Src-Y527F-GFP alone or together with Cav-1-monomeric red fluorescent protein (mRFP) in COS-7 cells, which were then subjected to FRAP-beam size analysis. Typical results are shown in Figure 1 , and quantitative data summarizing experiments on multiple cells are depicted in Figure 2 . The analysis used two laser beam sizes, generated using a 63× (smaller Gaussian radius, ω) or a 40× (larger ω) objective . The ratio between the illuminated areas, ω 2 (40×)/ω 2 (63×), was 2.28. For FRAP by lateral diffusion, τ (t 1/2 for recovery) reflects the characteristic diffusion time τ D , which is proportional to the laser-bleached area (τ D = ω 2 /4D, where D is the lateral diffusion coefficient). Therefore, for FRAP by lateral diffusion, the τ(40×)/τ(63×) ratio should equal the beam-size ratio (2.28). On the other hand, a τ ratio of 1 is indicative of FRAP by exchange between membrane-associated and cytoplasmic pools of the protein. In this case, τ is the characteristic exchange time τ ex , which is independent of the beam size. Intermediate τ ratios suggest mixed recovery Shvartsman et al., 2007) .
As shown in Figures 1 and 2 , the recovery rate of Src-Y527F-GFP was significantly slower than that of Src-WT-GFP, accompanied by a much higher τ(40×)/τ(63×) ratio for the constitutively active mutant. In fact, the τ ratio of Src-Y527F-GFP was not significantly different from the 2.28 beam-size ratio expected for recovery by pure lateral Courtneidge, 2002; Frame, 2004) . Using fluorescence recovery after photobleaching (FRAP) and FRAP beam-size analysis, we show that tyrosine phosphorylation of membrane proteins by Src is followed by binding of activated Src to the phosphorylated tyrosine (pTyr) sites via its SH2 domain and that this binding regulates Src membrane interactions and localization .
The membrane association and intracellular distribution of SFKs depend on their unique fatty-acylated N-terminal sequences (Brown and Cooper, 1996; Resh, 1999 Resh, , 2006 Sandilands et al., 2007) . Apart from the common N-myristoylation site, most SFKs (e.g., Fyn and Yes) contain one or two N-terminal palmitoylation sites, which are absent in Src (Resh, 1999) . Palmitoylation is important for targeting membrane-associated proteins to cholesterol-enriched, dynamic membrane assemblies commonly referred to as lipid rafts (Simons and Toomre, 2000; Hancock, 2006; Jacobson et al., 2007) and/or to caveolin-based caveolae, which can be viewed as a subset of rafts (Simons and Toomre, 2000; Anderson and Jacobson, 2002; Parton et al., 2006) . Palmitoylated SFKs are targeted to rafts/caveolae (Shenoy-Scaria et al., 1994; Robbins et al., 1995; Resh, 1999; Oneyama et al., 2009) , whereas the single myristoyl in Src is insufficient for raft association (Melkonian et al., 1999; Oneyama et al., 2009) . Accordingly, Src localization was reported to be mainly nonraft (Shenoy-Scaria et al., 1994; Mukherjee et al., 2003; Oneyama et al., 2008) , although some reports suggest partial association with rafts (Tansey et al., 2000; Veracini et al., 2006) . This conflict may reflect the major role of tyrosine-phosphorylated membrane proteins such as Csk-binding protein (Cbp, also called PAG) in recruiting Src to rafts/caveolae (Oneyama et al., 2008 (Oneyama et al., , 2009 .
Caveolin-1 (Cav-1) is the major protein component of caveolae (Liu et al., 2002; Razani et al., 2002; Parton et al., 2006) . It was first identified as a tyrosine phosphorylation target of v-Src in Rous sarcoma virus-transformed cells (Glenney and Zokas, 1989; Glenney and Soppet, 1992) and was found to be phosphorylated by Src at Tyr-14 Aoki et al., 1999; Lee et al., 2000) to produce pY14-Cav-1 (pCav-1). This phosphorylation has multiple functions, from recruitment of SH2-containing proteins (e.g., Csk or Grb7; Lee et al., 2000; Cao et al., 2002) to regulation of various cellular processes (Parat et al., 2003; del Pozo et al., 2005; Gaus et al., 2006; Grande-Garcia et al., 2007; Urra et al., 2012) . pCav-1 was reported to be present at or near focal adhesions (FAs; Lee et al., 2000; del Pozo et al., 2005; Gaus et al., 2006) and to enhance FA dynamics (Joshi et al., 2008) . However, this view was challenged by a study showing that the monoclonal anti-pY14-Cav-1 antibody used in the earlier studies also labels paxillin (Hill et al., 2007) .
The nature of the Src-Cav-1 interaction is unclear. Initially, it was proposed that it depends on the Cav-1 scaffolding domain and shows high preference for wild-type Src (Src-WT) over activated (viral) Src (Li et al., 1996a) . In contrast, a later study suggested that Cav-1 phosphorylation by Src depends on Cav-1 palmitoylation at Cys156 (Lee et al., 2001 ). However, more recent studies showed that Src is recruited to rafts/caveolae mainly by binding of its SH2 domain to phosphorylated Cbp, suggesting recruitment of activated Src; of note, the confinement to rafts/caveolae by raft-anchored Cbp suppressed SFK-mediated cell transformation (Oneyama et al., 2008 (Oneyama et al., , 2009 Resh, 2008) . This raises the intriguing possibility that Cav-1, which resembles Cbp in being a raft-localized Src phosphorylation target and in its ability to recruit Csk (Glenney and Zokas, 1989; Li et al., 1996b; Cao et al., 2002; Place et al., 2011) , can regulate Src signaling by targeting active Src to specific membrane regions. Here we show that after phosphorylation of Cav-1 by Src at Tyr-14, activated Src binds directly to pCav-1 via its SH2 domain. This interaction, which is sensitive to in a small, albeit significant increase in the τ values of Src-WT-GFP and a marked increase in the τ values of Src-Y527F-GFP (Figures 1 and 2A Rotblat et al., 2004) or for Src-WT-GFP (0.64 μm 2 /s), suggesting that the lateral diffusion of activated Src is retarded by interaction with slower-diffusing membrane proteins, including Cav-1 itself. These interactions must be transient, since they reduce the τ value of Src-Y527F rather than its mobile fraction. The limited effect of Cav-1 on the FRAP rates of Src-WT-GFP appears to be due to activation of a small fraction of Src-WT in the presence of serum, since under serum-starvation conditions the effects of Cav-1 on Src-WT-GFP recovery rates disappeared, whereas stimulation by platelet-derived growth factor (PDGF) restored the retardation of Src-WT-GFP diffusion by Cav-1 ( Figure 2C ). Note that reducing the expression of endogenous Cav-1 by Cav-1 small interfering RNA (siRNA) did not have a significant effect on Src-Y527F-GFP recovery in the FRAP studies (Figure 3 ), in line with our earlier demonstration that the lateral diffusion of Src-Y527F is retarded by interactions with multiple pTyr membrane protein targets . Because Src-Y527F-GFP is overexpressed relative to endogenous Cav-1, only a small fraction of Src-Y527F can bind to endogenous Cav-1, rendering the Cav-1 effect on Src-Y527F-GFP mobility undetectable. On overexpression of Cav-1, the fraction of membrane-associated Src-Y527F bound to Cav-1 increases, enabling the detection of the additional retardation by FRAP. Thus it is not feasible to fully prove functional Src-pCav-1 interactions at endogenous levels, and such confirmation should await further studies.
To complement these studies and corroborate the biophysical results with biochemical data, we measured Src-Cav-1 interactions by coimmunoprecipitation studies on cells expressing Src-WT-GFP or Src-Y527F-GFP with or without Cav-1-mRFP (Figure 4 ). Src-GFP proteins were precipitated from cell lysates with anti-Src or anti-GFP antibodies, followed by immunoblotting with antibodies to Cav-1, pCav-1, or GFP. Two bands of Cav-1-mRFP, one above and one just below 50 kDa, are coprecipitated with Src ( Figure 4A ). The upper band represents pCav-1 ( Figure 4C ), as demonstrated by its absence in 1) lysates of cells coexpressing Cav-1-mRFP and catalytically inactive Src-Y527F/ K295M (see Figure 6C , Cav-1 blot, lane 4) and 2) lysates of cells coexpressing Src-Y527F and Cav-1-Y14F ( see Figure 7C , panel 3, lane 3). Whereas pCav-1 represents a minor fraction of the total Cav-1 pool detected in cell lysates ( Figure 4A , panel 3), it is highly enriched in the Src immunoprecipitates (top), suggesting a highly diffusion. This enables us to calculate D directly from the τ value (which is τ D in this case), yielding 0.22 μm 2 /s. On the other hand, the τ ratio of Src-WT-GFP was intermediate between 2.28 and 1 (the ratio expected for recovery by exchange), suggesting weaker membrane interactions for Src-WT-GFP, which lead to faster dissociation from the membrane. The contribution of exchange does not permit accurate calculation of D, which, however, can be estimated from the τ(63×) value, as the smaller bleach area reduces τ D , resulting in a higher contribution to the FRAP of lateral diffusion relative to exchange . This calculation yields D = 0.64 μm 2 /s for Src-WT-GFP. These findings are in good agreement with our earlier results on Src-WT and Src-Y527F . Of importance, coexpression with Cav-1-mRFP resulted ; Student's t test). The dependence of the Cav-1 effect on Src activity is demonstrated by the weaker effect of Cav-1 on Src-WT. Moreover, the effect of Cav-1 on Src-WT appears to be due to serum activation of Src-WT, as it disappears after serum starvation (C, D). PDGF stimulation restored some of the Cav-1-mediated retardation; the effect is only partial, consistent with the notion that PDGF activates only a fraction of the Src-WT population (C). (B, D) τ(40×)/τ(63×) ratios. Bootstrap analysis (see Materials and Methods) shows that only the τ ratio of Src-WT (with or without Cav-1) is significantly different from the 2.28 beam-size ratio (p < 10
). This suggests that Src-WT has a lower affinity to the PM, resulting in mixedmode FRAP (lateral diffusion and exchange).
depletion were on the interactions between activated Src and Cav-1 rather than on the levels of pCav-1 or Cav-1, which remained unchanged (Figure 5, C and D) , whereas the level of pCav-1 coprecipitated with Src-Y527F was reduced significantly (Figure 5, C and E). These findings are consistent with the notion that the Cav-1-mediated retardation of Src-Y527F-GFP mobility is cholesterol dependent.
Cav-1-Src interactions require the Src SH2 domain and the phosphorylation of Cav-1 Tyr-14 by Src
To examine the roles of the different Src domains in its interactions with Cav-1, we coexpressed Cav-1-mRFP with Src-Y527F-GFP or the same protein carrying a second mutation that disabled a specific domain/function (kinase-dead Src-Y527F/K295M, SH2-defective Src-Y527F/R175A, or SH3-defective Src-Y527F/W118A). The cells were subjected to FRAP beam-size analysis to measure the effects of Cav-1 on Src-GFP membrane interaction dynamics. In accord with our previous studies , loss of Src kinase activity or SH2 function led to faster lateral diffusion, reflecting reduced binding to pTyr-protein targets in the plasma membrane ( Figure 6A ). On the other hand, the SH3-defective mutant not only did not diffuse faster, but even exhibited slower lateral diffusion, most likely due to its enhanced kinase activity, which generates more pTyr-protein targets at the plasma membrane (Erpel et al., 1995; Shvartsman et al., 2007) . Concomitantly, the τ ratio of this mutant was decreased, suggesting a somewhat increased contribution of exchange, as discussed by us earlier . Figure 6A shows that the retardation of the lateral diffusion of Src-Y527F mutants by Cav-1 also requires both the Src kinase activity and the function of its SH2 domain; the resemblance to the findings with the general population of pTyr-protein targets holds also for the SH3 mutant ( Figure 6A ), which exhibits somewhat stronger binding of pCav-1 than Src-Y527F ( Figure 6D ). Note that the lateral diffusion of the SH3 mutant is not further retarded by Cav-1 coexpression, most likely because this mutant is already maximally associated with a multitude of pTyr-protein targets in the membrane ( Figure 6A ). Although Cav-1 induces a minor increase in the Src-Y527F/W118A τ ratio ( Figure 6B ), it is below the significance limit. These conclusions were validated by coimmunoprecipitation studies of lysates of similarly transfected cells (Figure 6, C and D) , which showed that pCav-1 coprecipitated with Src-Y527F and with the SH3-defective mutant Src-Y527F-W118A (validating that they still interact) but not with the catalytically inactive Src-Y527F/K295M or the SH2-defective Src-Y527F/R175A.
To investigate the role of specific motifs in Cav-1 on its ability to modulate Src membrane interactions, we used FRAP beam-size analysis to investigate the effects of coexpression of a series of Cav-1-mRFP mutants on the mobility of Src-Y527F-GFP (Figure 7, A and B) . Mutation of the Cav-1 Tyr14 to Phe, which eliminates the Tyr14 phosphorylation site, abolished the retarding effect of Cav-1 on preferential association of pCav-1 with Src. Quantification of several such experiments ( Figure 4B ) shows that Src-Y527F coprecipitates a significantly higher amount of pCav-1 than Src-WT. These conclusions are further validated by the coprecipitation of pCav-1 (detected using anti-pCav-1 antibodies) with Src-Y527F-GFP and Src-WT-GFP (Figure 4, C and D) . Moreover, the same phenomenon was observed for the coprecipitation of endogenous pCav-1 with the Src-GFP proteins (Figure 4 , E and F). The increased interaction of Src-Y527F with pCav-1 detected in the immunoprecipitation assays correlates with the biophysical studies, indicating a high level of interaction of Cav-1 with active Src in live cells (Figures 1 and 2 ).
Interactions of activated Src with Cav-1 are cholesterol dependent
In view of the association of Cav-1 with cholesterol-enriched assemblies, particularly caveolae, we examined the effects of cholesterol depletion on the ability of Cav-1-mRFP overexpression to retard the lateral diffusion of Src-Y527F-GFP. To this end, cholesterol was depleted (or not; control) using metabolic inhibition of its synthesis (see Materials and Methods), and cells expressing Src-Y527F-GFP (with or without Cav-1) were subjected to FRAP beam-size analysis ( Figure 5, A and B) . Cholesterol depletion eliminated the Cav-1-mediated retardation in the lateral diffusion rate of Src-Y527F-GFP ( Figure 5A ), retaining the τ ratio at a level close to that of recovery by lateral diffusion ( Figure 5B ). The observed effects of cholesterol FIGURE 4: pCav-1 coprecipitates preferentially with Src-Y527F-GFP. COS-7 cells in 10-cm dishes were transfected with vectors encoding the indicated proteins (Materials and Methods). After 24 h, cells were lysed, and proteins were immunoprecipitated (IP) either with anti-Src (A, E) or anti-GFP (C). The immunoprecipitates were subjected to SDS gel electrophoresis (8.5% polyacrylamide, except in E, for which 12% gels were used) and immunoblotted (IB) using anti-Cav-1, anti-pCav-1, or anti-GFP antibodies. In A (top), pCav-1 was identified as the upper band in the Cav-1 doublet. The lower panels in A, C, and E demonstrate that the expression levels of Cav-1-mRFP or Src-GFP were similar under the different transfection combinations used (blotting control for whole lysates). In E, n.s. designates a nonspecific band coprecipitated with Src-GFP; note that in lane 3, the cells are transfected with GFP rather than with Src-GFP, and therefore the n.s. band does not appear. (B, D, F) Quantification by densitometry (means ± SEM, n = 3). Data are presented as coprecipitated pCav-1 (or Cav-1) levels normalized to the levels of immunoprecipitated Src-GFP in each sample, taking the value of pCav-1 coprecipitated with Src-Y527F-GFP as 100%. These experiments reveal a 2.5-fold higher coimmunoprecipitation of pCav-1-mRFP with Src-Y527F relative to Src-WT (B, D). This result was reproduced for endogenous Cav-1 (E, F). Asterisks indicate a significant difference between the pCav-1 levels coprecipitated with Src-Y527F relative to Src-WT (*p < 0.02, Student's t test).
Cav-1-C156S was coprecipitated with high efficiency. Taken together, these results suggest that Cav-1 phosphorylation at Tyr14 is essential for its association with activated Src, whereas the Cys156 palmitoylation site is dispensable for these interactions.
The dependence of Src-Cav-1 interactions on Cav-1 Tyr-14 and on Src kinase activity and SH2 domain function suggests that these Src-Y527F lateral diffusion. On the other hand, overexpression of Cav-1-C156S, a Cav-1 mutant that lacks the Cys156 palmitoylation site, was as effective as Cav-1 in decreasing Src-Y527F mobility. These findings were corroborated by the results of coimmunoprecipitation studies (Figure 7, C and D) , which showed that the Y14F mutation in Cav-1 abolished its coprecipitation with Src, whereas ). Cholesterol depletion eliminated the Cav-1-mediated retardation in the lateral diffusion rate of Src-Y527F-GFP. (B) τ(40×)/τ(63×) ratios. No significant effects of cholesterol depletion were observed. (C-E) Western blot and coimmunoprecipitation show reduced interactions between activated Src and pCav-1 after cholesterol depletion. COS-7 cells in 10-cm dishes were transfected with expression vectors encoding Cav-1-mRFP together with Src-Y527F-GFP or GFP (control) as described under Materials and Methods. At 24 h posttransfection, cells were lysed and subjected either to immunoblotting (IB) with anti-pCav-1, anti-Cav-1 (to determine total Cav-1), or anti-GFP (transfection control) or to immunoprecipitation (IP) with anti-Src, followed by blotting with anti-pCav-1 or anti-GFP as in Figure 4 . The levels of pCav-1 and Cav-1 were normalized for transfection efficiency according to the Src-GFP expression level in each sample, assigning the normalized level of Cav-1 in the untreated sample the value of 100%. Neither pCav-1 nor Cav-1 level was significantly altered by cholesterol depletion (C, D). On the other hand, cholesterol depletion significantly reduced the level of pCav-1 coprecipitated with Src-Y527F-GFP (C, E; **p < 0.01). These findings indicate that the effects of cholesterol depletion on Src-Y527F-GFP FRAP rates in A and B are due to modulation of interactions between activated Src and Cav-1.
Src to FAs suggests a requirement for phosphorylation of Cav-1 at Tyr-14 for this effect.
DISCUSSION
There is evidence that Src-membrane interactions are crucial for its signaling and may play an important role in directing active Src to defined cellular regions (Kamps et al., 1985; Buss et al., 1986; Resh, 1999 Resh, , 2006 Resh, , 2008 Shvartsman et al., 2007; Oneyama et al., 2008) . Although phosphorylation of Cav-1 by Src was reported to be involved in multiple cellular functions, different conclusions were reached on the interdependence of pCav-1 formation and Src localization and activity (Lee et al., 2000; Cao et al., 2002; del Pozo et al., 2005; Gaus et al., 2006; Grande-Garcia et al., 2007; Hill et al., 2007; Joshi et al., 2008; Urra et al., 2012) , and the nature of Src-Cav-1 interactions remained unclear Lee et al., 2001; Oneyama et al., 2008; Resh, 2008) . In the present study we demonstrate that Src displays dynamic interactions with the plasma membrane, which are enhanced and stabilized by Cav-1. We show that the mechanism involves the initial phosphorylation of Cav-1 at Tyr14 by Src, which is followed by binding of the SH2 domain of activated Src to pY14-Cav-1. These interactions promote localization of activated Src to FAs, the dynamics and function of which are known to be regulated by Src (Cary et al., 1996; Wary et al., 1998; Webb et al., 2004; Radel and Rizzo, 2005; Mitra and Schlaepfer, 2006; Yeo et al., 2006) .
We formerly used FRAP beam-size analysis to demonstrate that the association of Src with the plasma membrane is regulated by an autocatalytic process in which the phosphorylation of multiple membrane protein targets by Src is followed by enhanced binding of activated Src to the pTyr sites via its SH2 domain . In accord with these findings, the recovery of Src-WT-GFP in FRAP beam-size experiments was characterized by a mixture of lateral diffusion (with a lipid-like D value) and exchange, suggesting relatively weak membrane interactions (Figures 1 and  2 ). On the other hand, constitutively active Src-Y527F-GFP recovered by pure lateral diffusion (i.e., its exchange rate was significantly slower) and with a smaller D, suggesting stabilized membrane association due to binding to membrane proteins that diffuse more slowly (Figures 1 and 2 ; Shvartsman et al., 2007) . Although these findings indicate that Src-membrane association is regulated by its activity and interactions with membrane protein targets, the biological implications of these interactions remained unclear. To explore these issues in the context of Cav-1, a well-known Src target protein, we conducted FRAP beam-size analysis on Src-WT-GFP and Src-Y527F-GFP in cells coexpressing Cav-1-mRFP. Of note, Cav-1 markedly reduced the lateral diffusion rate of Src-Y527F-GFP but had no effect on the FRAP rates of unactivated Src-WT-GFP after serum starvation (Figure 2, C and D) . The dependence of the Src-Cav-1 interactions on Src activity is further exemplified by the partial retardation of the lateral diffusion of Src-WT by PDGF in cells coexpressing Cav-1 (Figure 2C ), most likely reflecting activation of a portion of the Src population. Moreover, the retarding effects of Cav-1 on the lateral diffusion of activated Src are cholesterol dependent ( Figure 5 ) and accompanied by reduced association of activated Src with pCav-1, as shown by coimmunoprecipitation ( Figure 5E ). The notion that Src-Cav-1 interactions require Src activity was validated by the highly preferential coimmunoprecipitation of Cav-1 with constitutively active Src versus Src-WT (Figure 4) . Given that Cav-1 is an established Src phosphorylation target, the requirement for Src activity is consistent with the selective coprecipitation of pCav-1, which migrates at a higher molecular weight relative to unphosphorylated Cav-1 (Figure 4) . interactions may involve direct binding of the Src SH2 domain to the pTyr residue at position 14 on Cav-1. To test this possibility, we performed far-Western blot experiments (Machida et al., 2007) to examine the binding of fusion proteins of glutathione S-transferase (GST) with the Src SH2 domain (GST-SH2) or with a mutated inactive SH2 domain (GST-SH2-R175A) to immunoprecipitated pCav-1 ( Figure 8A) . The results clearly demonstrate binding of GST-SH2, but not GST-SH2-R175A or GST, to pCav-1. The specificity of the assay is further demonstrated by the lack of GST-SH2 binding to blots derived from cells coexpressing Src-Y527F-GFP together with Cav-1-Y14F-mRFP ( Figure 8B) . Moreover, the same assay confirmed that the Src SH2 domain can effectively bind the Cav-1-C156S mutant ( Figure 8B ).
Phosphorylation of Cav-1 by Src enhances the targeting of activated Src to focal adhesions
Cbp, a raft-associated protein that serves as an SFK phosphorylation target, was shown to bind the SH2 domain of activated Src, thus recruiting the latter to rafts/caveolae; the elevated confinement of activated SFKs to rafts/caveolae by Cbp was also reported to suppress SFK-mediated cell transformation (Oneyama et al., 2008 (Oneyama et al., , 2009 Resh, 2008) . Our novel finding that Src-mediated phosphorylation of Cav-1 at Tyr14 is followed by the binding of Src (via its SH2 domain) to pCav-1 raised the possibility that Cav-1, which resembles Cbp in being a Src phosphorylation target and in its ability to recruit Csk (Glenney and Zokas, 1989; Li et al., 1996b; Cao et al., 2002) , might attenuate the targeting of activated Src to FAs in the same way as does Cbp. However, pCav-1 was also reported to be enriched at or near FAs (Lee et al., 2000; del Pozo et al., 2005; Gaus et al., 2006) ; although studies on pCav-1 localization by fluorescence microscopy are complicated by the cross-reactivity of anti-pY14-Cav-1 with phosphopaxillin (Hill et al., 2007) , biochemical evidence links pCav-1 to integrin engagement and FA signaling (Wary et al., 1998; Volonte et al., 2001; del Pozo et al., 2005; Radel and Rizzo, 2005; Gaus et al., 2006) , suggesting that pCav-1 might instead have an opposite effect to that of Cbp and enhance the targeting of activated Src to FAs. To distinguish between these possibilities, we conducted quantitative imaging studies to investigate the effects of Cav-1 expression on the targeting of activated Src-GFP to FAs. The experiments used REF52 cells growing on fibronectin-coated coverslips, which display very clear FAs (Figure 9 ). The cells were cotransfected with Src-Y527F-GFP alone or together with Cav-1-mRFP (WT or Y14F); after 24 h, they were fixed/permeabilized, labeled with anti-paxillin, and subjected to three-dimensional confocal imaging (see Materials and Methods). Western blot analysis ( Figure 9A) showed that the expression levels of Src-Y527F-GFP and Cav-1-mRFP (WT or Y14F) in all samples were similar. Cells expressing (or not expressing) Cav-1-mRFP were identified by the mRFP fluorescence. On each individual cell, the FA regions were detected by the concentrated paxillin immunolabeling; these regions were segmented and marked by SlideBook (see Materials and Methods). The total Src-GFP fluorescence in these marked pixels was divided by the paxillin fluorescence in the same region to obtain a calibrated measure of FA-associated Src-GFP in individual cells. For statistical analysis, we calculated the mean ± SEM of the Src-GFP/paxillin fluorescence intensity ratios from 50-70 cells in each condition. The results (Figure 9) clearly demonstrate that the effect of Cav-1 coexpression is opposite of that reported for Cbp: overexpression of Cav-1-WT but not Cav-1-Y14F with constitutively active Src leads to enrichment of the activated Src in FAs. The failure of Cav-1-Y14F to target activated FIGURE 6: The effects of Cav-1 on Src-membrane interactions depend on the Src SH2 domain and kinase activity. COS-7 cells were cotransfected with a vector encoding a Src-GFP derivative together with a Cav-1-mRFP-encoding vector or empty vector (see Materials and Methods). FRAP beam-size analysis studies were conducted as in Figure 4A . In accord with the FRAP studies, no pCav-1 (upper band in the Cav-1 doublet; C) coprecipitation with Src-Y527F-GFP was observed for the Y14F Cav-1 mutant, indicating that the coprecipitation requires phosphorylation of Tyr-14 (***p < 10
−10
). The expression levels of the Cav-1-mRFP mutants and of Src-GFP were similar in all cases (bottom two panels in C). ). Thus the ability of Cav-1 to retard the lateral diffusion of Src-GFP requires Src kinase activity and SH2-domain binding. For Src-Y527F/W118A, the effect of Cav-1 is masked by the enhanced membrane interactions of the SH3-defective Src mutant (see the text). (B) τ(40×)/τ(63×) ratios. Bootstrap analysis does not show significant effects on the τ ratios of any of the Src-GFP mutants upon cotransfection with Cav-1-mRFP (the minor increase in the τ ratio of Src-Y527F/W118A upon coexpression of Cav-1 is not significant). (C, D) Coimmunoprecipitation experiments. (C) A typical experiment; (D) quantification of three experiments by densitometry. Data are presented as pCav-1 (upper band in the doublet around 50 kDa) or Cav-1 (lower band) normalized to the levels of immunoprecipitated Src-GFP in each sample, taking the value of pCav-1 coprecipitated with Src-Y527F-GFP as 100%. The amounts of pCav-1 coprecipitated with kinasedead Src-Y527F/K295M or SH2-defective Src-Y527F/R175A were significantly lower relative to Src-Y527F (*p < 0.02); a similar phenomenon was obtained with unactivated Src-WT. The expression levels of Cav-1-mRFP and Src-GFP were similar under the different transfection combinations used (see two lower IB strips in C).
The dependence on Src kinase activity is also demonstrated by the failure of Cav-1 to retard the lateral diffusion of activated Src bearing a mutation that abrogates its kinase activity (Src-Y527F/K295M; Figure 6 , A and B), as well as the lack of Cav-1 coprecipitation with this mutant (Figure 6, C and D) . Moreover, in cells expressing the kinase-dead Src-Y527F mutant, no pCav-1 was detected already in the lysate ( Figure 6C , Cav-1 immunoblot panel), suggesting that Cav-1 phosphorylation is mediated primarily by the kinase activity of the transfected Src. In addition to the kinase activity of Src, the integrity of the Src SH2 domain is required for both Src-Cav-1 interactions and the Cav-1-mediated effects on Src-Y527F mobility, as both were impaired in the Src-Y527F/R175A mutant ( Figure 6 ). In contrast, the SH3 domain appears to be dispensable for Src-Cav-1 interactions (Figure 6 ).
The foregoing findings are in accord with a role for Src SH2 domain-pTyr interactions in regulating Src-Cav-1 association. To directly assess this hypothesis, we mutated the Src phosphorylation target residue on . In accord with all the foregoing results, Cav-1-Y14F failed to interact with Src-Y527F both in the lateral diffusion FRAP assay and in coimmunoprecipitation studies ( Figure 7 ). Of note, mutation of Cav-1 to eliminate the palmitoylation site at Cys-156 (Cav-1-C156S) did not reduce its association with Src-Y527F as measured by either FRAP or coimmunoprecipitation ( Figure 7 ). These results are in contrast with an earlier report that Cys-156 is important for Src-mediated Cav-1 phosphorylation (Lee et al., 2001) and are in good agreement with a role for interactions between the Src SH2 domain and pTyr-proteins (such as pTyrCbp) in the recruitment of activated Src to caveolae (Oneyama et al., 2008 (Oneyama et al., , 2009 Resh, 2008) . Strong support for the notion that the Src SH2 domain binds directly to pY14 on Cav-1 (as well as to Cav-1-C156S, but not to Cav-1-Y14F) is provided by far-Western studies (Figure 8 ) demonstrating the interaction of pCav-1 with the WT GST-SH2 of Src but not with GST-SH2-R175A (defective Src-SH2 mutant).
In view of the conflicting reports on the cellular localization of pCav-1 in FAs (Lee et al., 2000; del Pozo et al., 2005; Gaus et al., 2006; Hill et al., 2007) , we investigated the effects of Cav-1 overexpression on the localization of Src-Y527F-GFP in FAs. Our quantitative imaging studies (Figure 9 ) demonstrate that Cav-1, but not Cav-1-Y14F, enhances the localization of activated Src in FAs. These findings are in line with earlier biochemical studies, which reported pCav-1 to be involved in integrin engagement and FA signaling (Wary et al., 1998; Volonte et al., 2001; del Pozo et al., 2005; Radel and Rizzo, 2005; Gaus et al., 2006) .
On the basis of the results described, we propose a mechanism in which the initial binding of Src to Cav-1 throughout the plasma membrane (where Cav-1 is enriched in caveolae) is followed by phosphorylation of Cav-1 at Tyr-14 by Src. The SH2 domain of active Src (in the open conformation) subsequently binds directly and tightly to the pY14 residue on Cav-1 and follows the latter to FA regions. This results in enrichment of FAs in Src activity, which potentially affects FA dynamics and cell-matrix interactions (Cary et al., 1996; Webb et al., 2004; Radel and Rizzo, 2005; Mitra and Schlaepfer, 2006; Yeo et al., 2006) . This is a novel function for Cav-1, which may have implications for Src-mediated regulation of metastasis.
MATERIALS AND METHODS Reagents
Rabbit antibodies to , pCav-1 (Tyr 14; sc-101653), and GFP (FL) were obtained from Santa Cruz Biotechnology FIGURE 8: The Src SH2 domain can bind directly to p-Y14-Cav-1. COS-7 cells were transfected with vectors encoding the indicated proteins, lysed, and subjected to immunoprecipitation with anti-pCav-1, followed by SDS-PAGE and blotting as described under Materials and Methods. The blots were probed with GST fusion proteins, followed by rabbit anti-GST and peroxidase-goat anti-rabbit antibodies (Materials and Methods). For quantification, three independent experiments were subjected to densitometric analysis, taking the GST-SH2 labeling signal of the pCav-1 band obtained for Cav-1-mRFP coexpressed with Src-Y527F-GFP as 100%. (A) The Src SH2 domain binds to pCav-1 in far-Western blotting. The pCav-1 band is labeled by GST-SH2 but not by GST-SH2-R175A or GST alone. In the GFP-transfected samples, very little pCav-1 is present, resulting in negligible GST-SH2 binding. Asterisks indicate significant differences from GST-SH2 binding (***p <10 −10 ). (B) GST-SH2 binding requires phosphorylation of Cav-1 on Tyr-14. Far-Western labeling with GST-SH2 was observed for cells cotransfected with constitutively active Src and Cav-1-WT or Cav-1-C156S but not with Cav-1-Y14F (***P < 10 −10 relative to GST-SH2 binding in cells transfected with Cav-1 WT). The expression levels of total Cav-1 were similar (see total Cav-1 immunoblot, bottom).
Cell culture and transfections
COS-7 and REF52 cells (American Type Culture Collection) were grown in DMEM containing 10% fetal calf serum (FCS) as described (Shvartsman et al., 2003; Wolfenson et al., 2009 ) on glass coverslips (uncoated or precoated with 20 μg/ml fibronectin) placed in sixwell plates (for FRAP and imaging studies) or on 10-cm dishes (for biochemical experiments). COS-7 cells were cotransfected using DEAE-dextran (Sigma; Seed and Aruffo, 1987 ) with a vector encoding a Src-GFP derivative (0.15 μg of DNA; replaced by pEGFP-N1 in some biochemical control experiments) together with Cav-1-mRFP (WT or mutant; 0.3 μg) or empty pcDNA3.1 vector (control). REF52 cells were cotransfected by TransIT-LT1 (Mirus, Madison, WI) with the same vector combinations, using twofold higher DNA quantities.
siRNA-mediated expression knockdown experiments
COS-7 cells were grown on six-well plates (for biochemical experiments) or glass coverslips placed in six-well plates (for FRAP studies). They were cotransfected by jetPRIME (Polyplus, Illkirch, France) with a vector encoding Src-Y527F-GFP (0.15 μg) together with 50 nM ON-TARGETplus human Cav-1 SMART pool siRNA (Dharmacon, Lafayette, CO), target sequences CUAAACACCU-CAACGAUGA, GCAAAUACG UAGACUCGGA, GCAGUUGUAC-CAUGCAUUA, and GCAUCAA CUUGCAGAAAGA; or with 50 nM ON-TARGETplus nontargeting pool siRNA (Dharmacon; negative control). Immunoblotting analysis or FRAP studies were performed 48 h posttransfection as described in the relevant subsequent sections. blotting as described. After taking 10 μg of protein of each lysate to evaluate total Src-GFP or Cav-1-mRFP levels by immunoblotting, we subjected lysates (1 mg protein) to immunoprecipitation of Src-GFP by 2 μg of mouse anti-GFP or 2.5 μg of anti-Src antibodies essentially as described previously (Donaldson et al., 2000; Shvartsman et al., 2007) . Alternatively, Cav-1 (2 μg of rabbit antiCav-1) or pCav-1 (2 μg of mouse anti-pCav-1) was precipitated. Protein A-Sepharose (for polyclonal antibodies) or Protein G-Sepharose (for mouse antibodies) beads (Sigma) were blocked in HNTG buffer (20 mM HEPES, pH 7.5, 0.15 mM NaCl, 0.1% Triton X-100, 10% glycerol) containing 5% bovine serum albumin for 30 min at 22°C, followed by incubation with the antibodies for 30 min at 22°C. The beads were then incubated with the cell lysates for 2 h at 4°C. The complexes were washed three times in HNTG buffer, and the bound material was solubilized in 30 μl of SDS sample buffer and subjected to SDS-PAGE and immunoblotting as described.
Construction, expression, and purification of GST fusion proteins
Construction of a pGEX-KG plasmid encoding GST fused to the Src SH2 domain (chicken c-Src amino acids 148-251) was previously described . An analogous construct with an inactivating mutation in SH2, GST-SH2-R175A, was generated similarly, except that Src-Y527F/R175A served as a template for PCR amplification; the BamHI/HindIII-digested fragment was then recloned into the same sites of the pGEX-KG vector. To express the fusion constructs, transformed bacteria were grown in fresh LB medium for 2 h to A 550 = 0.5-1. Isopropyl β-d-1-thiogalactopyranoside was then added to 1 mM for an additional 4 h. The bacteria (250 ml) were harvested by centrifugation (5000 × g, 15 min, 4°C). Purification of the GST fusion proteins followed established protocols (Sambrook and Russell, 2001 ).
Far-Western blots
Transfected cells were subjected to lysis, immunoprecipitation with anti-pCav-1, SDS-PAGE. and blotting as described under Immunoblotting and immunoprecipitation. For the binding reaction, GST fusion proteins (or GST) were incubated with the blocked membrane in TBST (50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween 20) at a final concentration of 1.5 μg/ml for 1 h at 22°C. After three 10-min washes (22°C) with TBST, the blots were incubated (1 h, 22°C) with anti-GST (1:5000 in TBST), washed three times, and incubated with peroxidase-goat anti-rabbit IgG (1:10,000, 1 h, 22°C). After extensive wash, bound probe was detected by enhanced chemiluminescence and quantified by densitometry. head) microscope (Axiovert 200M; Carl Zeiss MicroImaging) with a Photometrics (Tucson, AZ) Evolve electron-multiplying chargecoupled device camera, under the control of SlideBook (Intelligent Imaging Innovations, Denver, CO). A 63×/1.4 NA oil immersion objective (Plan Apochromat) was used. Three dimensional (3D) image stacks were generated by sequential acquisition along the z-axis by varying the position of a piezoelectrically controlled stage (step size, 0.29 μm). GFP, mRFP, and Alexa 647 were excited with solid-state lasers at 473 nm (50 mW), 561 nm (50 mW), or 660 nm (100 mW), respectively. The image acquisition exposure time was 0.3 s. The 3D images were restored by nearest-neighbor deconvolution (Agard et al., 1989; Chetrit et al., 2009 ) using SlideBook. Cells expressing (or not expressing) Cav-1-mRFP were identified by the mRFP fluorescence. In each cell group, the FA regions were identified by the concentrated paxillin immunolabeling (using anti-paxillin followed by Alexa 647-goat-anti-mouse IgG). To mark the paxillinpositive pixels in these regions, images were intensity-based segmented with the paxillin-specific channel. The total Src-GFP fluorescence in these marked pixels was divided by the paxillin fluorescence in the same region to obtain a calibrated measure of FA-associated Src-GFP in individual cells. For statistical analysis, the mean ± SEM of the Src-GFP/paxillin fluorescence intensity ratios from 50-70 cells in each condition was calculated.
